-
Laquinimod is an
experimental immunomodulator developed by
Active Biotech and Teva. It is
being investigated as an oral
treatment for
multiple sclerosis...
-
fumarate Fingolimod Glatiramer acetate Interferon beta-1a
Interferon beta-1b
Laquinimod Mitoxantrone Monomethyl fumarate Natalizumab Ocrelizumab Ozanimod Ponesimod...
- (USAN)
lapirium chloride (INN)
laprafylline (INN) la****ucel-T (USAN)
laquinimod sodium (USAN)
larazotide (USAN)
Largon Lariam Larodopa laromustine (USAN)...
-
Amifampridine N07XX06 Tetrabe****ne N07XX07
Fampridine N07XX08
Tafamidis N07XX10
Laquinimod N07XX11
Pitolisant N07XX12
Patisiran N07XX13 Valbe****ne N07XX14 Edaravone...
-
Irinotecan Gianvi Irbesartan Junel Kariva Kelnor Lamotrigine Lansoprazole Laquinimod Letrozole Leucovorin Calcium Levonorgestrel branded as
Enpresse Loperamide...
-
ingredients and has
developed proprietary pharmaceuticals such as
Copaxone and
Laquinimod for the
treatment of
multiple sclerosis, and
Rasagiline for the treatment...
- oral
drugs are
still under investigation, the most
notable example being laquinimod,
which was
announced in
August 2012 to be the
focus of a
third phase III...
-
Trial for
Laquinimod in MS".
Medscape Medical News.
Retrieved 21 May 2013. He D, Han K, Gao X, et al. (August 2013). Chu L (ed.). "
Laquinimod for multiple...
- (Copaxone) is
being considered, and is
expected to work synergistically.
laquinimod and fampridine, with good results,
subject to
patent where applicable...
- Huntington's
Disease to ****ess the
Efficacy and
Safety of
Three Oral
Doses of
Laquinimod - Full Text View". ClinicalTrials.gov.
Retrieved 2016-03-31. Wild, EJ;...
